Skip to main content

Peer Review reports

From: Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy

Original Submission
19 Jun 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
20 Jun 2010 Author responded Author comments - Dragomir P. Zubac
Resubmission - Version 3
20 Jun 2010 Submitted Manuscript version 3
19 Aug 2010 Reviewed Reviewer Report - Sam Bhayani
14 Sep 2010 Reviewed Reviewer Report - Ted Skolarus
11 Nov 2010 Author responded Author comments - Dragomir P. Zubac
Resubmission - Version 4
11 Nov 2010 Submitted Manuscript version 4
28 Nov 2010 Author responded Author comments - Dragomir P. Zubac
Resubmission - Version 5
28 Nov 2010 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
1 Dec 2010 Author responded Author comments - Dragomir P. Zubac
Resubmission - Version 9
1 Dec 2010 Submitted Manuscript version 9
Publishing
3 Dec 2010 Editorially accepted
3 Dec 2010 Article published 10.1186/1471-2490-10-20

You can find further information about peer review here.

Back to article page